225 related articles for article (PubMed ID: 17921026)
1. Clinical use of FDG PET.
Hoh CK
Nucl Med Biol; 2007 Oct; 34(7):737-42. PubMed ID: 17921026
[TBL] [Abstract][Full Text] [Related]
2. PET and PET/CT in pediatric oncology.
Jadvar H; Connolly LP; Fahey FH; Shulkin BL
Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography/computed tomography: the current technology and applications.
Mittra E; Quon A
Radiol Clin North Am; 2009 Jan; 47(1):147-60. PubMed ID: 19195540
[TBL] [Abstract][Full Text] [Related]
4. Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases.
De Winter F; Vogelaers D; Gemmel F; Dierckx RA
Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):247-57. PubMed ID: 12072934
[TBL] [Abstract][Full Text] [Related]
5. Who should read and interpret 18F-FDG PET studies?
Fischman AJ; Thrall JH
J Nucl Med; 2003 Aug; 44(8):1197-9. PubMed ID: 12902407
[No Abstract] [Full Text] [Related]
6. PET/CT: challenge for nuclear cardiology.
Schwaiger M; Ziegler S; Nekolla SG
J Nucl Med; 2005 Oct; 46(10):1664-78. PubMed ID: 16204717
[TBL] [Abstract][Full Text] [Related]
7. Unparalleled contribution of 18F-FDG PET to medicine over 3 decades.
Basu S; Alavi A
J Nucl Med; 2008 Oct; 49(10):17N-21N, 37N. PubMed ID: 18832112
[No Abstract] [Full Text] [Related]
8. Considerations for generic oncology FDG-PET/CT protocol preparation in drug development.
Hallett WA; Maguire RP; McCarthy TJ; Schmidt ME; Young H
IDrugs; 2007 Nov; 10(11):791-6. PubMed ID: 17968761
[TBL] [Abstract][Full Text] [Related]
9. Added value of PET and PET-computed tomography in oesophageal cancer: a review of current practice.
Douis H; Jafri M
Nucl Med Commun; 2008 Sep; 29(9):840. PubMed ID: 18677217
[No Abstract] [Full Text] [Related]
10. The role of 18F-FDG PET in oncology: clinical and resource implications.
Al-Nahhas A; Win Z; Singh A; Khan S; Al-Sayed Y
Nucl Med Rev Cent East Eur; 2006; 9(1):1-5. PubMed ID: 16791796
[No Abstract] [Full Text] [Related]
11. Re: Fischman and Thrall editorial, "Who Should Read ... PET Studies".
Yaeger T
J Nucl Med; 2004 Nov; 45(11):1975. PubMed ID: 15534071
[No Abstract] [Full Text] [Related]
12. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.
Tateishi U; Hosono A; Makimoto A; Nakamoto Y; Kaneta T; Fukuda H; Murakami K; Terauchi T; Suga T; Inoue T; Kim EE
Ann Nucl Med; 2009 Feb; 23(2):155-61. PubMed ID: 19225939
[TBL] [Abstract][Full Text] [Related]
13. Impact of fluorodeoxyglucose PET on the management of esophageal cancer.
Salavati A; Basu S; Heidari P; Alavi A
Nucl Med Commun; 2009 Feb; 30(2):95-116. PubMed ID: 19194210
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG positron emission tomography CT (FDG PET-CT) in the management of pancreatic cancer: initial experience in 12 patients.
Saif MW; Cornfeld D; Modarresifar H; Ojha B
J Gastrointestin Liver Dis; 2008 Jun; 17(2):173-8. PubMed ID: 18568138
[TBL] [Abstract][Full Text] [Related]
15. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
[TBL] [Abstract][Full Text] [Related]
16. Practical Aspects of 18F-FDG PET When Receiving 18F-FDG from a Distant Supplier.
Ducharme J; Goertzen AL; Patterson J; Demeter S
J Nucl Med Technol; 2009 Sep; 37(3):164-9. PubMed ID: 19692456
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography.
Bar-Shalom R; Kagna O; Israel O; Guralnik L
Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145
[TBL] [Abstract][Full Text] [Related]
18. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
Wu ZJ; Zhang YX; Wei H; Jia Q
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
[TBL] [Abstract][Full Text] [Related]
19. [Positron emission tomography in oncology: an update].
Jerusalem G; Withofs N; Rorive A; Hustinx R
Rev Prat; 2007 Nov; 57(17):1864-70. PubMed ID: 18095621
[TBL] [Abstract][Full Text] [Related]
20. PET/CT for the staging and follow-up of patients with malignancies.
Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
